Two Research Achievements Presented at 2026 EHA Annual Meeting
Dr. Xiao Juan and Dr. Chen Jiao from Prof. Sun Yuan's team presented two research posters at the 31st European Hematology Association Annual Meeting in Stockholm, showcasing China's pediatric hematology expertise on the global stage.
📅 June 18, 2026
Phase III Clinical Trial Open for Children with ITP
Jingdu Children's Hospital is recruiting children aged 1–18 with primary immune thrombocytopenia (ITP) for a pivotal Phase III study of Romiplostim N01 (QL0911).
📅 June 12, 2026
"White Pupil" in a 1-Year-Old: Saved from Retinoblastoma
A 1-year-old girl diagnosed with eye cancer (retinoblastoma) was referred for eye removal. Through chemotherapy, laser therapy, and intra-arterial chemotherapy, Jingdu doctors saved her eye.
📅 June 5, 2026
Saved from Enucleation: An 8-Year-Old's Corneal Crisis
When Tiantian's corneal ulcer worsened rapidly, local doctors recommended eye removal. Director Liang Tianwei's team acted fast — and saved her eye.
📅 June 2026
Beating the Odds: Haploidentical Transplant for HLH
A 6-year-old with primary HLH received a modified haploidentical HSCT using the groundbreaking protocol by Prof. Wu Minyuan's team.
📅 Recently
Diagnosis Across Borders: A Pompe Disease Journey
A European family found answers at Jingdu Children's after a year of uncertainty. Gene testing confirmed Pompe disease, and enzyme replacement therapy began.
📅 Recently
A Heart Mended: Congenital Heart Disease Corrected
A 5-year-old from Africa with tetralogy of Fallot underwent successful surgical repair by Prof. Liu Yinglong's cardiac surgery team.
📅 Recently
Hope Beyond Borders: A Relapsed Leukemia Story
An 8-year-old boy from Southeast Asia with relapsed ALL found a second chance through innovative HSCT at Jingdu Children's Hospital.
📅 Recently